JAGUAR HEALTH, INC. Increase (Decrease) in Other Operating Assets
JAGUAR HEALTH, INC. (JAGX) reported Increase (Decrease) in Other Operating Assets of $17.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-04-01
- JAGUAR HEALTH, INC. increase (decrease) in other operating assets for fiscal 2023 was $17.00K, a 96.91% decline from fiscal 2022.
- JAGUAR HEALTH, INC. increase (decrease) in other operating assets for fiscal 2022 was $550.00K, a 34.80% increase from fiscal 2021.
- JAGUAR HEALTH, INC. increase (decrease) in other operating assets for fiscal 2021 was $408.00K.
- JAGUAR HEALTH, INC. increase (decrease) in other operating assets for fiscal 2020 was -$893.00K.
| Period end | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|
| 2023-12-31 | $17.00K 10-K · filed 2024-04-01 |
| 2022-12-31 | $550.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $408.00K 10-K · filed 2023-03-24 |
| 2020-12-31 | -$893.00K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |